Significance of PELP1/SETDB1 axis in endocrine therapy resistance.

被引：0
|
作者：
Liu, Zexuan [1 ]
Liu, Junhao [1 ]
Tang, Weiwei [1 ]
Pratap, Uday P. [1 ]
Altwegg, Kristin A. [1 ]
Ebrahimi, Behnam [1 ]
Li, Xiaonan [1 ]
Sareddy, Gangadhara R. [1 ]
Viswanadhapalli, Suryavathi [1 ]
Vadlamudi, Ratna K. [1 ]
机构：
[1] UT Hlth San Antonio, San Antonio, TX USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
733
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
    Zexuan Liu
    Junhao Liu
    Behnam Ebrahimi
    Uday P. Pratap
    Yi He
    Kristin A. Altwegg
    Weiwei Tang
    Xiaonan Li
    Zhao Lai
    Yidong Chen
    Liangfang Shen
    Gangadhara R. Sareddy
    Suryavathi Viswanadhapalli
    Rajeshwar R. Tekmal
    Manjeet K. Rao
    Ratna K. Vadlamudi
    Breast Cancer Research, 24
  • [2] SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
    Liu, Zexuan
    Liu, Junhao
    Ebrahimi, Behnam
    Pratap, Uday P.
    He, Yi
    Altwegg, Kristin A.
    Tang, Weiwei
    Li, Xiaonan
    Lai, Zhao
    Chen, Yidong
    Shen, Liangfang
    Sareddy, Gangadhara R.
    Viswanadhapalli, Suryavathi
    Tekmal, Rajeshwar R.
    Rao, Manjeet K.
    Vadlamudi, Ratna K.
    BREAST CANCER RESEARCH, 2022, 24 (01)
  • [3] Therapeutic significance of ERα-PELP1 axis in blocking endocrine therapy resistance
    Cortez, Valerie A.
    Suzuki, Takayoshi
    Miyat, Naoki
    Sood, Anil K.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2011, 71
  • [4] PELP1、SETDB1在卵巢癌组织中的表达及意义
    黄吉仁
    李长江
    毛艳华
    张文文
    王佳
    谢乐乐
    张应凤
    重庆医学, 2023, 52 (20) : 3099 - 3103+3109
  • [5] Proto-oncogene PELP1 interactions with SETDB1 contribute to aberrant activation of AKT1 in breast cancer
    Liu, Zexuan
    Liu, Junhao
    Tang, Weiwei
    Pratap, Uday P.
    Altwegg, Kristin A.
    Li, Xiaonan
    Viswanadhapalli, Suryavathi
    Vadlamudi, Ratna
    CANCER RESEARCH, 2021, 81 (04)
  • [6] PELP1: A review of PELP1 interactions, signaling, and biology
    Girard, Brian J.
    Daniel, Andrea R.
    Lange, Carol A.
    Ostrander, Julie H.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 382 (01) : 642 - 651
  • [7] PELP1 regulation of mTOR Axis: Role in breast cancer progression and resistance
    Gonugunta, Vijaya Kumar
    Valerie, Cortez
    Roy, Sudipa Saha
    Sareddy, Gangadhar Reddy
    Nair, Binoj C.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2012, 72
  • [8] Significance of PELP1 signaling in liver cancer progression
    Pratap, Uday
    Nassar, Khaled Mohamed
    Yang, Xue
    Baker, Adriana
    Gopalam, Rahul
    Arnold, William C.
    Adeniran, Timilehin
    Hernandez Fernandez, Marian Helena
    Sareddy, Gangadhara R.
    Viswanadhapalli, Suryavathi
    Sun, Luzhe
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Significance and therapeutic potential of PELP1 axis in ER-negative breast cancer
    Vadlamudi, Ratna K.
    Roy, Sudipa Saha
    CANCER RESEARCH, 2011, 71
  • [10] PELP1: Structure, biological function and clinical significance
    Sareddy, Gangadhara Reddy
    Vadlamudi, Ratna K.
    GENE, 2016, 585 (01) : 128 - 134
12345